Krsnaa Diagnostics
724.30
-29.05(-3.86%)
Market Cap₹2,349.50 Cr
PE Ratio29.22
Company Performance:
1D-3.86%
1M-10.93%
6M+0.98%
1Y-22.12%
5Y-26.62%
View Company Insightsright
More news about Krsnaa Diagnostics
11Aug 25
Krsnaa Diagnostics Reports Robust Q1 Performance with 13% Revenue Growth
Krsnaa Diagnostics announced robust Q1 financial results, with consolidated revenue increasing 13% to 1,930.00 million rupees. EBITDA rose 19% to 524.00 million rupees, and net profit grew 15% to 205.00 million rupees. The company served 5 million patients and performed 16 million tests. Retail expansion led to a significant increase in touchpoints from 362 to 2,414, with retail revenue surging from 15.00 million to 118.00 million rupees. Krsnaa plans to expand to over 200 CT/MRI centers and has secured a major project in Rajasthan under the National Health Mission.
05Aug 25
Krsnaa Diagnostics Secures Major Contract with National Health Mission in Rajasthan
Krsnaa Diagnostics, in consortium with Telecommunications Consultants India Ltd. (TCIL), has signed an agreement with the National Health Mission, Rajasthan to provide laboratory services under the Free Diagnostics Initiative. The partnership involves implementing a HUB and SPOKE model for diagnostic services across the state. While the contract size is currently unestimated, this new project is expected to expand Krsnaa Diagnostics' presence in Rajasthan's public health sector.
05Aug 25
Krsnaa Diagnostics Secures Contract for Free Diagnostic Services in Rajasthan
Krsnaa Diagnostics and Telecommunications Consultants India Ltd. (TCIL) have signed an agreement with the National Health Mission, Rajasthan to provide laboratory services under the Free Diagnostics Initiative. The contract involves implementing a HUB and SPOKE Model for laboratory services across Rajasthan, aiming to enhance accessibility to diagnostic services, especially in remote areas. The exact contract size is undisclosed due to the project's novel nature. This agreement represents a significant opportunity for Krsnaa Diagnostics to expand its presence in Rajasthan's public health sector.
07Jul 25
Krsnaa Diagnostics Secures License to Provide Free Lab Services in Rajasthan
Krsnaa Diagnostics has been awarded a new license by the Rajasthan government to provide free laboratory services across the state. This development follows a recent court ruling and aligns with the company's mission to improve healthcare accessibility. The license allows Krsnaa Diagnostics to operate and offer a range of diagnostic services at no cost to patients throughout Rajasthan, potentially benefiting residents who previously faced financial barriers to essential tests. This strategic expansion strengthens Krsnaa's position in the public health sector and demonstrates its commitment to partnering with state authorities.
12May 25
Krsnaa Diagnostics Reports Strong Q4 Results with Improved EBITDA, Net Profit, and Recommends Dividend
Krsnaa Diagnostics announced robust Q4 financial results, with revenue increasing 12% year-over-year to 1.86 billion rupees. EBITDA grew 21.3% to 530 million rupees, with an improved margin of 28.48%. Net profit rose 10.7% to 207 million rupees. The company's annual revenue increased by 25.65% to 636.40 crore rupees. A dividend of 2.75 rupees per share has been recommended.
Krsnaa Diagnostics
724.30
-29.05
(-3.86%)
1 Year Returns:-22.12%
Industry Peers
Dr. Lal Path Labs
3,096.70
(-0.36%)
Vijaya Diagnostic Centre
1,023.60
(+0.55%)
Metropolis Healthcare
1,963.90
(-2.09%)
Thyrocare Technologies
1,391.10
(+5.05%)
Krsnaa Diagnostics
724.30
(-3.86%)
Suraksha Diagnostic
319.65
(-1.59%)
3B BlackBio DX
1,327.50
(+0.24%)
Sastasundar Ventures
289.65
(-0.07%)
Choksi Laboratories
142.25
(-0.18%)